Hybrid nanoparticles (HNPs) that integrate organic and inorganic components have been recognized as one of the most sophisticated solutions in the field of nanomedicine to surpass the physiological limitations of the blood-brain barrier (BBB). By the combination of biocompatibility, flexibility, and the capacity of functionalization of the organic shells with the magnetic, optical, or structural precision of the inorganic cores, HNPs provide receptor-mediated transport, controlled drug release, and multimodal imaging with high efficiency. This review details the molecular mechanisms of HNPs crossing the BBB, such as receptor-mediated, adsorptive, carrier-mediated, and biomimetic transcytosis, and also points to the role of the advanced conjugation chemistries like EDC/NHS coupling, thiol‑gold anchoring, click reactions, and redox-cleavable linkers in enhancing targeting fidelity. The therapeutic improvements in the major neurological diseases, i.e., Alzheimer's disease, Parkinson's disease, Huntington's disease, and glioblastoma, are discussed with the help of figures, which illustrate enhanced bioavailability, gene silencing, mitochondrial targeting, and integrated photothermal or magnetic responsiveness. Moreover, the review discusses potential diagnostic applications such as multimodal MRI/PET/NIR-II imaging, molecular biosensing, and theranostic nanoplatforms, which link the real time visualization with the targeted treatment. To conclude, we point out the upcoming directions comprising biomimetic coatings, AI guided nanoparticle design, stimuli responsive logic-gated systems, and clinically scalable biodegradable hybrids. In sum, HNPs embody a radically different strategy to precision neuro-nanomedicine, thereby providing a seamless avenue for diagnosis, targeted therapy, and continuous disease monitoring within a single intelligent nanosystem.